Leadership

Our proven executive team brings deep, diverse cell therapy and oncology experience and is committed to developing safe, effective, and accessible NK cell therapies for cancer. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.

Brian Daniels, M.D.
Brian Daniels, M.D.
Chairperson
View Bio »
Fred Aslan, M.D.
Fred Aslan, M.D.
President and Chief Executive Officer
View Bio »
Yong-Jun Huh
Yong-Jun Huh
Director
View Bio »
Elizabeth Hougen
Elizabeth Hougen
Director
View Bio »
Yu-Kyeong Hwang, Ph.D.
Yu-Kyeong Hwang, Ph.D.
Director
View Bio »
Bong Koh, M.D.
Bong Koh, M.D.
Director
View Bio »
Linda Kozick
Linda Kozick
Director
View Bio »
Laura Stoppel, Ph.D.
Laura Stoppel, Ph.D.
Director
View Bio »
Yvonne Yamanaka, Ph.D.
Yvonne Yamanaka, Ph.D.
Director
View Bio »